MBX Biosciences, Inc. Common Stock
Status: Publicly traded
Direct answer
MBX Biosciences, Inc. Common Stock is publicly traded on NASDAQ under the ticker MBX.
MBX Biosciences, Inc. is a biopharmaceutical company in its clinical development phase, dedicated to pioneering precise peptide-based therapies for endocrine and metabolic conditions. Its most advanced drug candidate, MBX 2109, is a parathyroid hormone peptide prodrug currently in Phase 2 clinical trials. This medication is being evaluated as a long-duration hormone replacement treatment for individuals suffering...
Can you invest in MBX Biosciences, Inc. Common Stock?
Yes. MBX Biosciences, Inc. Common Stock trades publicly on NASDAQ as MBX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for MBX Biosciences, Inc. Common Stock
Detailed equity research is provided by MarketSnap.